What is Gene therapy and how is it used in curing sickle cell disease?

Gene therapy is a medical technique that involves altering the genes inside a person's cells to treat or prevent disease. It aims to correct defective genes responsible for disease development or to introduce new genes to help fight diseases. In the case of sickle cell disease, gene therapy works by modifying the patient's hematopoietic stem cells (HSCs). Here’s how it is used: 1. Collection of Stem Cells: Blood is drawn from the patient to collect HSCs, which are responsible for producing blood cells. 2. Gene Modification: The collected HSCs are then genetically modified in the laboratory. This often involves using a viral vector to deliver a healthy copy of the β-globin gene, which is defective in sickle cell disease. 3. Reintroduction: The modified HSCs are infused back into the patient’s bloodstream. These cells can now produce healthy red blood cells that do not sickle. 4. Monitoring: After the infusion, the patient is monitored to ensure that the new cells are functioning properly and producing healthy blood cells. This approach has shown promise in clinical trials, potentially offering a cure for sickle cell disease by enabling the production of normal hemoglobin.